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Calcium is an important messenger in every cell type. Its intra-
cellular level is regulated by finely tuned machinery responsible
for calcium uptake, release, and intracellular storage. T cells are
no exception in this regard. Pathways of calcium homeostasis par-
ticipate in a number of cellular processes that determine short
and long-term function of T lymphocytes. Over the recent year,
an increasing number of calcium channels and transporters have
been described that play a key role in balancing cytoplasmic cal-
cium levels in T cells. Therapeutic strategies are now evolving
based on the modulation of T-lymphocyte calcium homeostasis
in order to combat immune-mediated disorders.
Submissions in this Research Topic include reviews on the ion
channels that regulate calcium influx from the extracellular space
in T cells (1,2),either by conducting calcium ions or by modulating
the membrane potential that provides the driving force for calcium
influx (3, 4). The best characterized calcium channel in T cells
is the calcium release-activated calcium (CRAC) channel, which
is composed of ORAI and stromal interaction molecule (STIM)
proteins. Several other channels may also mediate calcium influx
directly in T cells including members of the transient receptor
potential (TRP) family, P2X receptors, and voltage-gated calcium
(Cav) channels. While the role of CRAC channels to T-cell func-
tion is well described by findings in ORAI1 and STIM1-deficient
patients and mice (5, 6), the contributions of TRP, Cav1, and P2X
receptor channels remain to be more clearly defined. These chan-
nels could contribute to calcium influx in specific T-cell subsets
at distinct stages of T-cell development or following stimuli other
than T-cell receptor (TCR) engagement.
Special attention is given to the emerging roles of Cav1 chan-
nels and their integration with other channels to generate a spe-
cific calcium signature in T lymphocytes (7, 8). The relationships
between STIM, ORAI, and Cav1 will be discussed. For instance,
STIM was shown to be a negative regulator of Cav1 signaling
(9). Furthermore, the involvement of Cav1 channels as players
in human disease will also be explored. In a recent study, a mix-
ture of Cav1.2 and Cav1.3 specific antisense oligodeoxynucleotides
strongly impaired the TCR-dependent increase of cytoplasmic cal-
cium level and cytokine production in Th2 cells without any effect
on Th1 cells, thus protecting mice against the development of
asthma (10). These findings suggest that these channels may rep-
resent an interesting new approach in the treatment of allergic
diseases.
The role of autophagy, a pathway for intracellular degrada-
tion in calcium homeostasis in T cells will also be reviewed
(11). Autophagy regulates calcium signaling by developmentally
maintaining the homeostasis of the ER (12).
Second messengers derived from the adenine dinucleotides,
nicotinamide adenine dinucleotide (NAD), and nicotinamide ade-
nine dinucleotide phosphate (NADP) have also been implicated
in T-cell calcium signaling (13). Nicotinic acid adenine dinu-
cleotide phosphate (NAADP) acts as a very early second messenger
upon TCR/CD3 engagement, while cyclic ADP-ribose (cADPR)
is mainly involved in sustained partial depletion of the endo-
plasmic reticulum by stimulating calcium release via ryanodine
receptors. Finally, adenosine diphosphoribose (ADPR), a break-
down product of both NAD and cADPR activates the TRPM2
cation channel, thereby facilitating calcium (and sodium) entry
into T cells. Receptor-mediated formation, metabolism, and mode
of action of these novel second messengers in T lymphocytes
will be reviewed. Their involvement in immune regulation also
makes these pathways suitable targets for therapeutic intervention.
The NAADP antagonist BZ194 has recently been shown to ame-
liorate the clinical course of transfer experimental autoimmune
encephalitis, an animal model of multiple sclerosis (14).
While the crosstalk between calcium signaling and metabolic
regulation in T cells is relatively poorly understood, one of the con-
tributions highlights where such interactions occur (15). Calcium
is known not only to mediate T-cell activation but it also modulates
the unique metabolic changes that occur in distinct T-cell subsets
and developmental stages. The crosstalk between mitochondrial
metabolism, reactive oxygen species (ROS) generation, and CRAC
channel activity will be highlighted.
In the course of lymphocyte activation, potassium channels
maintain the driving force for sustained calcium influx from the
extracellular milieu as they grant the efflux of potassium from the
cytoplasm, thus conserving an electrochemical potential gradient
between the intra- and extracellular spaces. There are two major
types of potassium channels in T cells: the voltage-gated Kv1.3
and the calcium-activated IKCa1 channels. The relation between
the calcium currents through CRAC channels and the efflux of
potassium makes the proliferation and activation of lympho-
cytes sensitive to pharmacological modulation of Kv1.3 and IKCa1
channels (16), and provides an opportunity for targeted interven-
tion that will also be discussed (17). Specific inhibition of these
channels results in a diminished calcium influx in lymphocytes
and a lower level of lymphocyte activation.
Finally, a quantitative mathematical model of T-lymphocyte
calcium dynamics will be introduced that has been developed
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in order to establish a tool which helps to disentangle cause-
effect relationships between ion fluxes and observed calcium time
courses (18).
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